Crossref
HIF‐1α and PD‐L1 as Predictive Efficacy Markers for Neoadjuvant Chemoradiotherapy in Rectal Cancer
World Journal of Surgery · 2026-05 · 50 (5) · 1148-1149
DOI: 10.1002/wjs.70353 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Surgery, online erschienen am 05.04.2026. Verfasst von Samir Johna. Beteiligte Einrichtung: Bernard Tyson Kaiser Permanente School of Medicine, Pasadena, California, USA. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Bernard Tyson Kaiser Permanente School of Medicine, Pasadena, California, USA.
- Loma Linda University School of Medicine California, Linda, California, USA.
Zitieren
APA
Johna, S. (2026). HIF‐1α and PD‐L1 as Predictive Efficacy Markers for Neoadjuvant Chemoradiotherapy in Rectal Cancer. World Journal of Surgery, 50(5), 1148-1149. https://doi.org/10.1002/wjs.70353
Vancouver
Johna S. HIF‐1α and PD‐L1 as Predictive Efficacy Markers for Neoadjuvant Chemoradiotherapy in Rectal Cancer. World Journal of Surgery. 2026;50(5):1148-1149. doi:10.1002/wjs.70353
BibTeX
@article{Johna2026,
author = {Johna, Samir},
title = {HIF‐1α and PD‐L1 as Predictive Efficacy Markers for Neoadjuvant Chemoradiotherapy in Rectal Cancer},
journal = {World Journal of Surgery},
year = {2026},
volume = {50},
number = {5},
pages = {1148--1149},
doi = {10.1002/wjs.70353}
}
EUVIMED